Anti-Angiogenesis Drug Discovery and Development: Volume 3

Volume in the series

Anti-Angiogenesis Drug Discovery and Development

Publisher:Bentham Science

By: Atta-ur Rahman and M. Iqbal Choudhary

Paid access

|Oct 2016

E-Book €144.99Institutions €577.95

Description

The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases wound healing disorders etc. Efforts to understand the molecular basis both for inhibition and induction have yielded fascinating results.
Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. The feast of these reader-friendly reviews on topics of great scientific importance – many of which are considered significant medical breakthroughs makes this book excellent reading both for the novice as well as for expert medicinal chemists and clinicians.
This volume brings together 5 reviews on these topics:
-Beta-blockers for treating premature retinopathy
-Anti-angiogenic activity of disintegrin-based synthetic cyclic KTS peptides
-Anti-angiogenic therapy of lung cancer
-Oral anti-angiogenic therapy for NSCLC
-Angiogenesis in hepatocellular carcinoma

Authors

Metrics

PDF ISBN: 978-1-68108-155-7

Publisher: Bentham Science

Publication date: 2016

Language: English

Pages: 233

Related subjects:

Medicine,

Clinical medicine,

Pharmacology, toxicology